(Q34511854)

2 August 2017

title

Azo reduction of sulphasalazine in healthy volunteers (English)

1 reference

2 August 2017

Houston JB

1

1 reference

2 August 2017

Day J

series ordinal

2

1 reference

2 August 2017

Walker J

series ordinal

3

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 September 1982

1 reference

British Journal of Clinical Pharmacology

2 August 2017

published in

1 reference

2 August 2017

volume

14

1 reference

2 August 2017

issue

3

1 reference

2 August 2017

page(s)

395-398

1 reference

Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427633

Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427633

Saliva: plasma concentration relationships for sulphapyridine following sulphasalazine administration to normal volunteers and patients with inflammatory bowel disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427633

A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphazalazine (Salazopyrin).

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427633

Determination of sulphapyridine and its metabolites in biological materials after administration of salicylazosulphapyridine.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427633

An experiment to determine the active therapeutic moiety of sulphasalazine

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427633

National Cooperative Crohn's Disease Study: results of drug treatment

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427633

Salivary excretion and pharmacokinetics of sulfapyridine after sulfasalazine

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427633

Clinical Pharmacokinetics of Sulphasalazine

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427633

The role of intestinal bacteria in the metabolism of salicylazosulfapyridine

7 July 2018

1 reference

12 December 2020

Absorption, metabolism, and excretion of salicylazosulfapyridine in man

1 reference

12 December 2020

Therapeutic Efficacy of Sulfasalazine and Its Metabolites in Patients with Ulcerative Colitis and Crohn's Disease

1 reference

12 December 2020

FACTORS AFFECTING ACETYLATION IN-VIVO OF PARA-AMINOBENZOIC ACID BY HUMAN SUBJECTS

1 reference

12 December 2020

10.1111/J.1365-2125.1982.TB01997.X

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/gypzelbarzcmldyxbg22peepx4

30 July 2022

release_gypzelbarzcmldyxbg22peepx4

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/gypzelbarzcmldyxbg22peepx4

30 July 2022

https://api.fatcat.wiki/v0/release/gypzelbarzcmldyxbg22peepx4

1 reference

30 July 2022

https://api.fatcat.wiki/v0/release/gypzelbarzcmldyxbg22peepx4

1 reference

30 July 2022